Baker McKenzie’s practice covers high-yield offerings, related LME matters, and leveraged finance products. Key figures include Adam Farlow.
Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • Good at ad hoc structures and very good as a sounding board.
  • B&M has an excellent HY team with in-depth and varied experience in the field. The team is client-centric, offers solution-oriented services, and is a great team to work with. It is always a pleasure to interact and work with them. I highly recommend the HY team as a top HY practice.
  • Relative to peers, the practice is notably solutions-driven. Rather than defaulting to conservative positions, the team engages constructively with clients to find workable structures that align legal risk with commercial reality. This makes a meaningful difference on challenging transactions or where execution certainty is critical. The team has also shown thought leadership and has great expertise in HY transactions in emerging market jurisdictions.
  • The individuals are highly engaged and display strong commercial intuition. Partners are accessible and hands-on, particularly at key negotiation points, and have a good sense of how far market terms can be pushed without compromising execution. Associates are a particular strength of the practice – they are proactive, thoughtful, and capable of anticipating issues before they crystallize. The team also works very collaboratively with clients’ in-house teams, which creates a sense of partnership rather than a traditional adviser relationship. Shout-out to Fani Chlampoutaki for delivering consistently excellent client service on every transaction she's involved in.

Key clients

  • Bank of America
  • Barclays
  • Biocartis Group NV
  • BofA Securities
  • BNP PARIBAS
  • Citibank
  • Deutsche Bank
  • Deutsche Trustee Company Limited
  • Emirates NBD
  • Erdemir
  • EquipmentShare.com Inc.
  • eToro Group Ltd

Work highlights

Advised the syndicate of 10 underwriters on the multi-tranche USD 2.3 billion (equivalent) (upsized from USD 2 billion) SEC-registered bond offering by certain subsidiaries of Teva Pharmaceutical Industries Limited.
Advised the initial purchasers on InPost S.A.’s issuance of EUR 850 million 4.000% Senior Notes due 2031.
Advised EquipmentShare on its USD 500 million consent solicitations relating to amendments to its 2028 and 2032 senior secured second lien notes.

Lawyers

Leading partners

The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.

Other key lawyers

Adam Farlow